Participants 226 311 7
patients between 22 weeks and 42 weeks of gestation with anticipated vaginal delivery
Participants 861 983 5
A total of 848 patients were enrolled and 756 randomly assigned, 377 in the misoprostol group and 379 in the placebo group
Participants 985 1073 3
Demographic, antepartum, and intrapartum characteristics were similar between the groups
